These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 205836)

  • 1. [Does the association of liver carcinoma and alpha-1-antitryptin deficiency exist? Does it have a diagnostic significance?].
    Beaugrand M; Garnier JP; Ferrier JP; Buffet C; Vercaigne D; Martin JP
    Nouv Presse Med; 1978 Mar; 7(11):939-40. PubMed ID: 205836
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO
    Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR; Ishak KG; Benjamin SB; Knuff TE
    Arch Pathol Lab Med; 1982 Dec; 106(13):678-81. PubMed ID: 6291490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic significance of hepatoma specific gamma-glutamyltranspeptidase].
    Kitahara T; Kawase H; Watanabe Y; Fujisawa K
    Rinsho Byori; 1982 May; 30(5):492-6. PubMed ID: 6127421
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-1-antitrypsin deficiency and liver disease.
    Millward-Sadler GH
    Acta Med Port; 1981; (Suppl 2):91-102. PubMed ID: 6263065
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression and clinical significance of telomerase hTRT in primary hepatocellular carcinoma].
    Zhou YJ; Zhang XF; Lu HS; Huang CM; Yang FD; Wang C
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):500. PubMed ID: 15329219
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
    Lieberman J; Silton RM; Agliozzo CM; McMahon J
    Am J Clin Pathol; 1975 Sep; 64(3):304-10. PubMed ID: 169686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha 1-antitrypsin phenotype PiMZ, a risk factor for liver cirrhosis but not for liver cancers in Thailand.
    Smanadhikorn P; Pongpaew P; Srivatanakul P; Tungtrongchitr R; Supanaranond W; Schelp FP; Migasena P
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):240-2. PubMed ID: 8629052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha 1-antitrypsin deficiency and the liver (author's transl)].
    Spech HJ; Liehr H
    Z Gastroenterol; 1982 Jul; 20(7):393-404. PubMed ID: 6287750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary liver carcinoma: deficiency of alpha 1-antitrypsin].
    Clerc M; Le Bras M; Loubière R; Houvet D
    Nouv Presse Med; 1977 Oct; 6(34):3061-4. PubMed ID: 411116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA; Nichols WS; Kim S; Tolmachoff T; Lee S; Dycaico MJ; Felts K; Sorge JA
    Hepatology; 1994 Feb; 19(2):389-97. PubMed ID: 8294096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detecting the gamma-glutamyltransferase mRNA-H in the peripheral blood of primary hepatocellular carcinoma patients].
    Han GQ; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):630-1. PubMed ID: 14572351
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of serum GPDA-F determined by immunoelectrophoresis in diagnosis of hepatocellular carcinoma].
    Liu HD; Ni RZ; Xiao MB; Li LR; Hua GP; Kuai XL
    Ai Zheng; 2006 Feb; 25(2):247-9. PubMed ID: 16480596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of the combined determination of serum alpha-1-antitrypsin and alpha-1-antichymotrypsin for primary hepatocellular carcinoma].
    Xu KC; Wei Q; Meng XY
    Zhonghua Nei Ke Za Zhi; 1987 Jan; 26(1):27-9, 63. PubMed ID: 3036437
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype].
    Labadie H; Sesboué R; Martin JP; Beaugrand M
    Gastroenterol Clin Biol; 1985 Dec; 9(12):881-5. PubMed ID: 3007258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological markers in hepatocellular carcinoma].
    Deugnier Y; David V; Leray G; Blayau M; Le Gall JY
    Ann Biol Clin (Paris); 1988; 46(1):85-8. PubMed ID: 2455460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of serum alpha 1-antitrypsin in chronic hepatopathies and its diagnostic significance].
    Tartaglino B; Macrì G; Molino G; Furlani D; Sansalvadore F
    Quad Sclavo Diagn; 1980 Dec; 16(4):451-8. PubMed ID: 6166021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma.
    Keiser HR; Vogel CL; Sadikali F
    J Natl Cancer Inst; 1972 Nov; 49(5):1251-5. PubMed ID: 4119495
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man].
    van den Hazel SJ; Meijer JW; van den Elshout FJ; de Vries RA
    Ned Tijdschr Geneeskd; 2000 Nov; 144(47):2269-72. PubMed ID: 11109473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency.
    Fargion S; Bissoli F; Fracanzani AL; Suigo E; Sergi C; Taioli E; Ceriani R; Dimasi V; Piperno A; Sampietro M; Fiorelli G
    Hepatology; 1996 Nov; 24(5):1161-4. PubMed ID: 8903392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.